Guangzhou Financial Statements From 2010 to 2024
| GU5 Stock | EUR 2.14 0.04 1.90% |
Check Guangzhou Baiyunshan financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Guangzhou Baiyunshan's main balance sheet or income statement drivers, such as , as well as many indicators such as . Guangzhou financial statements analysis is a perfect complement when working with Guangzhou Baiyunshan Valuation or Volatility modules.
Guangzhou |
Guangzhou Baiyunshan Pharmaceutical Company Profit Margin Analysis
Guangzhou Baiyunshan's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Guangzhou Baiyunshan Profit Margin | 0.06 % |
Most of Guangzhou Baiyunshan's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Guangzhou Baiyunshan Pharmaceutical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Guangzhou Baiyunshan Pharmaceutical has a Profit Margin of 0.0552%. This is 100.49% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The profit margin for all Germany stocks is 104.35% lower than that of the firm.
Guangzhou Baiyunshan Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Guangzhou Baiyunshan's current stock value. Our valuation model uses many indicators to compare Guangzhou Baiyunshan value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Guangzhou Baiyunshan competition to find correlations between indicators driving Guangzhou Baiyunshan's intrinsic value. More Info.Guangzhou Baiyunshan Pharmaceutical is rated # 4 in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about 0.28 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Guangzhou Baiyunshan Pharmaceutical is roughly 3.60 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Guangzhou Baiyunshan's earnings, one of the primary drivers of an investment's value.About Guangzhou Baiyunshan Financial Statements
Guangzhou Baiyunshan stakeholders use historical fundamental indicators, such as Guangzhou Baiyunshan's revenue or net income, to determine how well the company is positioned to perform in the future. Although Guangzhou Baiyunshan investors may analyze each financial statement separately, they are all interrelated. For example, changes in Guangzhou Baiyunshan's assets and liabilities are reflected in the revenues and expenses on Guangzhou Baiyunshan's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Guangzhou Baiyunshan Pharmaceutical. Please read more on our technical analysis and fundamental analysis pages.
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited engages in the research, development, manufacture, and sale of Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and chemical raw material intermediates in the Peoples Republic of China and internationally. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited was incorporated in 1997 and is based in Guangzhou, China. GUANG BAIY operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 25168 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Guangzhou Stock
Guangzhou Baiyunshan financial ratios help investors to determine whether Guangzhou Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Guangzhou with respect to the benefits of owning Guangzhou Baiyunshan security.